CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Beryl Drugs Ltd.

NSE : BSE : 524606 ISIN CODE : INE415H01017Industry : Pharmaceuticals

News

  • Beryl Drugs - DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015 21 Mar 2026 | 17:28 | Dion Global

    DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS 2015more...

  • Beryl Drugs - DISCLOSURE UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS)REGULATIONS, 2011 21 Mar 2026 | 17:22 | Dion Global

    DISCLOSURE UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS 2011more...

  • Beryl Drugs - Board Meeting Intimation for Consider And Approve The Date And Notice Of Extra Ordinary General Meeting (EOGM) 20 Mar 2026 | 17:52 | Dion Global

    Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/04/2026 inter alia to consider and appro...more...

  • Beryl Drugs - SUBMISSION OF DISCLOSURE UNDER REGULATION 7(2) 17 Mar 2026 | 13:08 | Dion Global

    SUBMISSION OF DISCLOSURE UNDER REGULATION 7(2)more...

  • Beryl Drugs - SUBMISSION OF DISCLOSURE UNDER REGULATION 29(2) 17 Mar 2026 | 12:59 | Dion Global

    SUBMISSION OF DISCLOSURE UNDER REGULATION 29(2)more...

  • Beryl Drugs - Regulations 7 (2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 14 Mar 2026 | 14:33 | Dion Global

    DISCLOSURE RECEIVED UNDER REGULATION 7(2) OF SECURITIES EXCHANGE BOARD OF INDIA(PROHIBITION OF INSIDER TRADING) REGULATIONS 2015more...

  • Beryl Drugs - Submission Of Disclosure Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 14 Mar 2026 | 14:24 | Dion Global

    DISCLOSURE UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS 2011 RECEIVED FROM MR. SUDHIR SETHI PROMOTER ...more...

  • Beryl Drugs - Submission Of Disclosure Under Regulations 7 (2) Of Securities And Exchange Board Of India (Prohibition Of Insi 13 Mar 2026 | 15:31 | Dion Global

    DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS 2015more...

  • Beryl Drugs - Submission Of Disclosure Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 13 Mar 2026 | 15:28 | Dion Global

    DISCLOSURE RECEIVED FROM MR. SUDHIR SETHI UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS 2011more...

  • Beryl Drugs - Submission Of Disclosure Under Regulations 7 (2) Of Securities And Exchange Board Of India (Prohibition Of Insi 12 Mar 2026 | 16:38 | Dion Global

    Disclosure under Regulation 7(2) of SEBI (Prohobition of Insider Trading) Regulations 2015more...

  • Beryl Drugs - Submission Of Disclosure Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 12 Mar 2026 | 16:35 | Dion Global

    Disclosure recieved from the Mr. sudhir sethi promoter of the company under regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers...more...

  • Beryl Drugs - Submission Of Disclosure Under Regulations 7 (2) Of Securities And Exchange Board Of India (Prohibition Of Insi 11 Mar 2026 | 14:17 | Dion Global

    DISCLOSURE UNDER REGULATION 7(2) OF PROHIBITION OF INSIDER TRADINGmore...

  • Beryl Drugs - Submission Of Disclosure Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 11 Mar 2026 | 14:10 | Dion Global

    disclosure received from Mr. sudhir sethi tthe main promoter of the company under regulation 29(2) of SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAK...more...

  • Beryl Drugs posts Q3 net loss of Rs 0.17 cr 09 Feb 2026 | 17:40 | Dion Global

    The company reported standalone net loss during the quarter stood at Rs 0.17 crore compared to net profit of Rs 0.05 crore in the previous y...more...

  • Beryl Drugs - UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2025 09 Feb 2026 | 16:43 | Dion Global

    UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER 2025more...

  • Beryl Drugs - Board Meeting Outcome for OUTCOME OF BOARD MEETING 09 Feb 2026 | 16:38 | Dion Global

    OUTCOME OF BOARD MEETINGmore...

  • Beryl Drugs - Board Meeting Intimation for To Consider And Approve The Unaudited Quarterly Financial Results For The Quarter 31 Jan 2026 | 19:55 | Dion Global

    Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and appro...more...

  • Beryl Drugs Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 10 Jan 2026 | 14:42 | Dion Global

    As of December 2025 26.38% is owned by Indian Promoters and 73.62% by Public. Top four Promoters holding highest number of shares of Beryl D...more...

  • Beryl Drugs Ltd. - Compliance-57 (5) : intimation after the end of quarter 06 Jan 2026 | 23:23 | Dion Global

    NON APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 31.12.2025more...

  • Beryl Drugs Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 06 Jan 2026 | 23:22 | Dion Global

    COMPLIANCE CERTIFICATE UNDER REGULATION 74(5) FOR THE QUARTER ENDED 31ST DECEMBER 2025more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex74018.611.82%
NSE Index22914.951.78%
B500DIVL503352.691.25%
BSE 1000 9776.131.91%
BSE 100LCTMC8485.371.71%
BSE Auto 54168.072.25%

Commodity

Gold1398182.92%
Silver2228416.26%
Copper1171.4187.25%
Crude Oil827529.03%
Lead191.6542.60%
Mentha Oil1103.83.41%
Nickel1584.2106.57%

Currency

USD/INR 93.35(0.97 %)
GBP/INR 125.16(1.23 %)
EUR/INR 107.94(1.10 %)
JPY/INR 0.59(1.21 %)
CAD/INR 67.34(0.00 %)
HKD/INR 11.80(0.02 %)